BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Phenobarbital
,
rs4950928
,
FABP1
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
envelope proteins viral
Summary
General Info
Curated Studies
Most Correlated Studies
PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
B cells activated with anti-IgM and CpG DNA then treated with high affinity HIV gp120 protein R66M
Dorsal root ganglia from rats modeling neuropathic pain by treatment with gp120 with ddC
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
Structure of a dengue virus envelope protein late-stage fusion intermediate.
Lysyl Oxidase-like Protein Recognizes Viral Envelope Proteins and Bacterial Polysaccharides against …
Mass spectrometric analysis of hepatitis C viral envelope protein E2 reveals extended microheterogen…
T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins contro…
Tetramerization of white spot syndrome virus envelope protein VP33 and its interaction with VP24.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy
A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. T…
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant …
Viral Inhibition in Children for Treatment of RSV
Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ